The European Commission has formally adopted a new procedure that will allow small and medium-sized enterprises to use a new procedure for certifying their early quality and nonclinical data on advanced therapy medicinal products1,2.
The regulation (Regulation (EC) No 668/2009), which was published in the Official Journal on 25 July, explains the procedure that will be operated by the European Medicines Agency’s Committee for Advanced Therapies...
Please Login to read the full article.
